Pilar Más

Treatment response in relation to inflammatory and axonal surrogate marker in multiple sclerosis

Axel Petzold, David Brassat, Pilar Más et al. · Multiple Sclerosis Journal · 2004 · 48 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Caustic ingestion: development and validation of a prognostic score

Joan Toscá, Rosana Villagrasa, Ana Sanahuja et al. · Endoscopy · 2020 · 14 citations · Full text

Medicine, Internal Medicine, Surgery +13

Clinical assessment of risk factors for infection in inflammatory bowel disease patients

Joan Toscá, N Álvarez García, Isabel Pascual et al. · International Journal of Colorectal Disease · 2020 · 13 citations

Veterinary Medicine, Immunology, Infectious Diseases +15

Low dose alpha interferon therapy can be effective in chronic active hepatitis C. Results of a multicentre, randomised trial.

J.M. Sánchez‐Tapias, Xavier Forns, Sergi Ampurdanés et al. · Gut · 1996 · 11 citations · Full text

Pharmacy, Internal Medicine, Pharmacology +14

Implementation and assessment of a fast-track programme to improve communication between primary and specialized care in patients with suspected cancer: how to shorten time between initial symptoms of cancer, diagnosis and initiation of treatment

María Teresa Martínez, Noelia Tarazona, Susana Roselló et al. · Clinical & Translational Oncology · 2014 · 10 citations

Medicine, Family Medicine, Oncology +16